| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 58.411 | 71.821 | 60.895 | 35.666 | 37.098 |
| Total Income - EUR | - | - | - | - | - | 94.004 | 71.881 | 60.895 | 35.666 | 37.947 |
| Total Expenses - EUR | - | - | - | - | - | 48.284 | 26.783 | 29.885 | 28.174 | 30.085 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 45.721 | 45.098 | 31.010 | 7.492 | 7.862 |
| Net Profit/Loss - EUR | - | - | - | - | - | 45.136 | 44.466 | 30.492 | 7.189 | 6.950 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Antomi Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 37.826 | 73.271 | 61.311 | 49.728 | 37.953 |
| Current Assets | - | - | - | - | - | 11.603 | 15.913 | 47.134 | 24.189 | 21.549 |
| Inventories | - | - | - | - | - | 1.683 | 1.815 | 1.796 | 2.275 | 2.614 |
| Receivables | - | - | - | - | - | 5.205 | 12.508 | 45.042 | 21.456 | 18.406 |
| Cash | - | - | - | - | - | 4.715 | 1.589 | 295 | 459 | 530 |
| Shareholders Funds | - | - | - | - | - | 45.178 | 83.285 | 102.449 | 64.532 | 53.711 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 4.252 | 5.899 | 5.996 | 9.386 | 5.791 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Antomi Med S.r.l.